Could Merck’s Molnupiravir and Pfizer’s Paxlovid, the Two New Anti-Viral Drugs Against COVID-19 Hasten the End of the Pandemic?

Could Merck’s Molnupiravir and Pfizer’s Paxlovid, the Two New Anti-Viral Drugs Against COVID-19 Hasten the End of the Pandemic?

Molnupiravir, the world’s first oral drug (approved by MHRA, UK) against COVID-19 along with upcoming drugs such as Paxlovid and sustained vaccination drive has raised hopes that the
#AntiviralDrug #COVID #COVID19 #Merck #Molnupiravir #Paxlovid #Pfizer
Umesh Prasad and Rajeev Soni

--

--

--

Editor, Scientific European SCIEU

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

This morning we officially became part of the rapidly increasing Covid-19 statistics.

Finding a Cure for COVID-19

Swiss Cheese is What We Need in Fighting Covid

Health Department Clears Up Controversial Face Masks Law

Health Department Clears Up Controversial Face Masks Law

Omicron Covid-19 Variant May Hinder Thailand’s Reopening Plans

A resilient routine.

The Cuban Strategy for Combatting the COVID-19 Pandemic

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Umesh Prasad

Umesh Prasad

Editor, Scientific European SCIEU

More from Medium

Katz’s. It’s the pastrami, stupid!

Zoombombing The Italian Senate

Image

weeklyOLM #3 (6th Jan 2022)

‘But I can’t draw!’ and 4 other lies you tell yourself about learning visual communication